501 - 510 of 6564 Results
Title
Year
- Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages2022OPENTitle: Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophagesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 34End Page: 34Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00297-9Best OA location URL: https://www.nature.com/articles/s41531-022-00297-9.pdfCitation Count: 44
-
OPENTitle: Serine/Threonine Protein Phosphatase 2A Regulates the Transport of Axonal MitochondriaJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page: 852245End Page: 852245Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2022.852245Best OA location URL: https://doi.org/10.3389/fncel.2022.852245Citation Count: 6
-
OPENTitle: Multivariate genomic and transcriptomic determinants of imaging-derived personalized therapeutic needs in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 5483End Page: 5483Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-09506-0Best OA location URL: https://www.nature.com/articles/s41598-022-09506-0.pdfCitation Count: 7
-
OPENTitle: Sensor Measurements Can Characterize Fluctuations and Wearing Off in Parkinson’s Disease and Guide Therapy to Improve Motor, Non-motor and Quality of Life ScoresJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 852992End Page: 852992Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.852992Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.852992/pdfCitation Count: 14
-
OPENTitle: Multi-modality machine learning predicting Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page: 35End Page: 35Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00288-wBest OA location URL: https://www.nature.com/articles/s41531-022-00288-w.pdfCitation Count: 152
-
OPENTitle: Characterisation of the Function of a SINE-VNTR-Alu Retrotransposon to Modulate Isoform Expression at the MAPT LocusJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page: 815695End Page: 815695Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2022.815695Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2022.815695/pdfCitation Count: 17
-
OPENTitle: CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative BiomarkersJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page: 834580End Page: 834580Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.834580Best OA location URL: https://doi.org/10.3389/fneur.2022.834580Citation Count: 36
-
OPENTitle: Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension StudyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page: 773999End Page: 773999Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.773999Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.773999/pdfCitation Count: 13
-
OPENTitle: Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson’s disease (randomized controlled trial)Journal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page: 274End Page: 274Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-022-06160-9Best OA location URL: https://trialsjournal.biomedcentral.com/track/pdf/10.1186/s13063-022-06160-9Citation Count: 7
-
OPENTitle: Defining Utility Values for Chorea Health States in Patients with Huntington’s DiseaseJournal Name: Advances in TherapyPublisher: Springer Science and Business Media LLCVol: 39Issue #: 4Start Page: 1784End Page: 1793Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s12325-022-02046-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12325-022-02046-z.pdfCitation Count: 6